# SIVEXTRO

NDC: 67919-040
Generic name: tedizolid phosphate
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20140620

FDA application: NDA205436

## Active ingredients

- TEDIZOLID PHOSPHATE: 200 mg/4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67919-040"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67919-040
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75672079-589f-451a-bdbf-eaebcfcc80a9